Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977 May;70(5):330–331. doi: 10.1177/003591577707000509

Cellular autoimmunity to muscle: a review.

M Esiri
PMCID: PMC1543074  PMID: 327480

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramsky O., Aharonov A., Webb C., Fuchs S. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol. 1975 Jan;19(1):11–16. [PMC free article] [PubMed] [Google Scholar]
  2. Aharonov A., Kalderon N., Silman I., Fuchs S. Preparation and immunochemical characterization of a water-soluble acetylcholine receptor fraction from the electric organ tissue of the electric eel. Immunochemistry. 1975 Sep;12(9):765–771. doi: 10.1016/0019-2791(75)90227-x. [DOI] [PubMed] [Google Scholar]
  3. Alpert L. I., Rule A., Norio M., Kott E., Kornfeld P., Osserman K. E. Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle. Am J Clin Pathol. 1972 Dec;58(6):647–653. doi: 10.1093/ajcp/58.6.647. [DOI] [PubMed] [Google Scholar]
  4. Armstrong R. M., Nowak R. M., Falk R. E. Thymic lymphocyte function in myasthenia gravis. Neurology. 1973 Oct;23(10):1078–1083. doi: 10.1212/wnl.23.10.1078. [DOI] [PubMed] [Google Scholar]
  5. Behan W. M., Behan P. O., Simpson J. A. Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1975 Nov;38(11):1039–1047. doi: 10.1136/jnnp.38.11.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brownell B., Oppenheimer D. R., Spalding J. M. Neurogenic muscle atrophy in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1972 Jun;35(3):311–322. doi: 10.1136/jnnp.35.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Currie S., Saunders M., Knowles M., Brown A. E. Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med. 1971 Jan;40(157):63–84. [PubMed] [Google Scholar]
  8. Dawkins R. L., Eghtedari A., Holborow E. J. Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol. 1971 Sep;9(3):329–337. [PMC free article] [PubMed] [Google Scholar]
  9. Dawkins R. L. Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol. 1965 Oct;90(2):619–625. doi: 10.1002/path.1700900231. [DOI] [PubMed] [Google Scholar]
  10. Dawkins R. L., Mastaglia F. L. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med. 1973 Mar 1;288(9):434–438. doi: 10.1056/NEJM197303012880903. [DOI] [PubMed] [Google Scholar]
  11. Esiri M. M., MacLennan I. C. Experimental myositis in rats. I. Histological and creatine phosphokinase changes, and passive transfer to normal syngeneic rats. Clin Exp Immunol. 1974 May;17(1):139–150. [PMC free article] [PubMed] [Google Scholar]
  12. Esiri M. M., MacLennan I. C., Hazleman B. L. Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol. 1973 May;14(1):25–35. [PMC free article] [PubMed] [Google Scholar]
  13. Fuchs S., Nevo D., Tarrab-Hazdai R., Yaar I. Strain differences in the autoimmune response of mice to acetylcholine receptors. Nature. 1976 Sep 23;263(5575):329–330. doi: 10.1038/263329a0. [DOI] [PubMed] [Google Scholar]
  14. Goldstein G., Whittingham S. Experimental autoimmune thymitis. An animal model of human myasthenia gravis. Lancet. 1966 Aug 6;2(7458):315–318. doi: 10.1016/s0140-6736(66)92599-2. [DOI] [PubMed] [Google Scholar]
  15. Goust J. M., Castaigne A., Moulias R. Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis. Clin Exp Immunol. 1974 Sep;18(1):39–47. [PMC free article] [PubMed] [Google Scholar]
  16. Green D. P., Miledi R., Vincent A. Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond B Biol Sci. 1975 Apr 29;189(1094):57–68. doi: 10.1098/rspb.1975.0041. [DOI] [PubMed] [Google Scholar]
  17. Haas D. C., Arnason B. G. Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol. 1974 Sep;31(3):192–196. doi: 10.1001/archneur.1974.00490390074008. [DOI] [PubMed] [Google Scholar]
  18. Heilbronn E., Mattsson C., Stålberg E., Hilton-Brown P. Neurophysiological signs of myasthenia in rabbits after receptor antibody development. J Neurol Sci. 1975 Jan;24(1):59–64. doi: 10.1016/0022-510x(75)90008-8. [DOI] [PubMed] [Google Scholar]
  19. Houseley J., Oppenheim J. J. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. Br Med J. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Johnson R. L., Fink C. W., Ziff M. Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest. 1972 Sep;51(9):2435–2449. doi: 10.1172/JCI107057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kakulas B. A. Destruction of differentiated muscle cultures by sensitised lymphoid cells. J Pathol Bacteriol. 1966 Apr;91(2):495–503. doi: 10.1002/path.1700910225. [DOI] [PubMed] [Google Scholar]
  22. Kalden J. R., Williamson W. G., Irvine W. J. Experimental myasthenia gravis, myositis and myocarditis in guinea-pigs immunized with subcellular fractions of calf thymus or calf skeletal muscle in Freund's complete adjuvant. Clin Exp Immunol. 1973 Jan;13(1):79–88. [PMC free article] [PubMed] [Google Scholar]
  23. Lennon V. A., Lindstrom J. M., Seybold M. E. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann N Y Acad Sci. 1976;274:283–299. doi: 10.1111/j.1749-6632.1976.tb47693.x. [DOI] [PubMed] [Google Scholar]
  24. Lisak R. P., Zweiman B. Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis. J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):521–524. doi: 10.1136/jnnp.38.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Manghani D., Partridge T. A., Sloper J. C. The role of myofibrillar fraction of skeletal muscle in the production of experimental polymyositis. J Neurol Sci. 1974 Dec;23(4):489–503. doi: 10.1016/0022-510x(74)90022-7. [DOI] [PubMed] [Google Scholar]
  26. Morgan G., Peter J. B., Newbould B. B. Experimental allergic myositis in rats. Arthritis Rheum. 1971 Sep-Oct;14(5):599–609. doi: 10.1002/art.1780140507. [DOI] [PubMed] [Google Scholar]
  27. Namba T., Nakata Y., Grob D. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis. Ann N Y Acad Sci. 1976;274:493–515. doi: 10.1111/j.1749-6632.1976.tb47710.x. [DOI] [PubMed] [Google Scholar]
  28. Parkes J. D. Attempted production of myasthenia gravis in the rat. Br J Exp Pathol. 1966 Dec;47(6):577–585. [PMC free article] [PubMed] [Google Scholar]
  29. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 1973 May 25;180(4088):871–872. doi: 10.1126/science.180.4088.871. [DOI] [PubMed] [Google Scholar]
  30. Santa T., Engel A. G., Lambert E. G. Histometric study of neuromuscular junction ultrastructure. II. Myasthenic syndrome. Neurology. 1972 Apr;22(4):370–376. doi: 10.1212/wnl.22.4.370. [DOI] [PubMed] [Google Scholar]
  31. Saunders M., Knowles M., Currie S. Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):569–571. doi: 10.1136/jnnp.32.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES